goralatide has been researched along with Adenocarcinoma, Basal Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bignon, J; Fromes, Y; Katsoris, P; Kovacevic, M; Lallemand, JY; Lawrence, F; Liu, JM; Papadimitriou, E; Potier, P; Wdzieczak-Bakala, J | 1 |
1 other study(ies) available for goralatide and Adenocarcinoma, Basal Cell
Article | Year |
---|---|
The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo.
Topics: Abdominal Wall; Adenocarcinoma; Allantois; Animals; Cell Differentiation; Cell Fusion; Cell Line, Transformed; Cell Movement; Cells, Cultured; Chick Embryo; Chorion; Collagen; Drug Combinations; Drug Implants; Endothelium, Vascular; Enzyme Activation; Enzyme Induction; Humans; Laminin; Lung Neoplasms; Matrix Metalloproteinase 1; Neovascularization, Physiologic; Oligopeptides; Proteoglycans; Rats; Rats, Wistar; Tumor Cells, Cultured; Umbilical Veins | 2003 |